Literature DB >> 6540864

Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria.

P Robberecht, P De Neef, M Waelbroeck, J C Camus, J Fontaine, J Christophe.   

Abstract

Secretin stimulated adenylate cyclase activity in crude membrane preparations from right and left rat atria, when tested in the presence of the potentiating activator forskolin. Its maximal effect on adenylate cyclase activity was greater in the right atrium than in the left atrium but the peptide efficiency was lower, in both atria, than that of D,L-isoproterenol. Secretin stimulated the rate of contraction of the spontaneously beating right atrium, but less efficiently than D,L-isoproterenol. Although this positive chronotropic action of secretin was inhibited by D,L-propranolol, it was probably not mediated by the release of endogenous catecholamines as: a) the inhibitory effects of D- and L-propranolol were similar and b) the efficiency of secretin on the in vitro beating of right atrium was the same in control and reserpinized rats. Secretin stimulated the force of contraction of spontaneously beating right atrium, even in the presence of propranolol, i.e. when the chronotropic effect of secretin was abolished. The hormone exerted also a positive inotropic effect on the electrically stimulated rat atrium. This effect was blocked neither by tetrodotoxin nor by propranolol. When comparing the dose-effect curves of secretin and D,L-isoproterenol on adenylate cyclase activation on the one hand, and on the stimulation of rate and contractility on the other hand, it is tempting to suggest that cyclic AMP might be involved in the modulation by secretin of the mechanical properties of rat atria.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540864     DOI: 10.1007/bf00581525

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  26 in total

Review 1.  Cyclic AMP and contractile activity in heart.

Authors:  R W Tsien
Journal:  Adv Cyclic Nucleotide Res       Date:  1977

2.  High efficiency coupling between beta-adrenergic receptors and cardiac contractility: direct evidence for "spare" beta-adrenergic receptors.

Authors:  J C Venter
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

3.  Effect of secretin on pacemaker activity and contractility in the isolated blood-perfused atrium of the dog.

Authors:  S Chiba
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Mar-Apr       Impact factor: 2.557

4.  Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.

Authors:  P Chatelain; P Robberecht; P De Neef; M Deschodt-Lanckman; W König; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

5.  The positive inotropic-acting forskolin, a potent adenylate cyclase activator.

Authors:  H Metzger; E Lindner
Journal:  Arzneimittelforschung       Date:  1981

6.  Inhibition of forskolin-stimulated cardiac adenylate cyclase activity by short-chain alcohols.

Authors:  P Robberecht; M Waelbroeck; P Chatelain; J C Camus; J Christophe
Journal:  FEBS Lett       Date:  1983-04-05       Impact factor: 4.124

7.  Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species.

Authors:  P Chatelain; P Robberecht; M Waelbroeck; P De Neef; J C Camus; A N Huu; J Roba; J Christophe
Journal:  Pflugers Arch       Date:  1983-04       Impact factor: 3.657

Review 8.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

9.  The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats.

Authors:  P Robberecht; P De Neef; J C Camus; M Waelbroeck; J Fontaine; J Christophe
Journal:  Pflugers Arch       Date:  1983-08       Impact factor: 3.657

10.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.